WelbeHealth Modesto Center Opens to Serve Medically Frail Seniors by Seini Moimoi | Sep 30, 2022 | Portfolio News
IntelyCare Launches The IntelyHeart Foundation, Committing $2M to Support Healthcare Professionals by Seini Moimoi | Sep 28, 2022 | Portfolio News
Ceribell Closes $50 Million Equity Financing Round Led by Ally Bridge Group by Seini Moimoi | Sep 21, 2022 | Portfolio News
Ceribell Receives FDA Breakthrough Device Designation for Delirium Indication by Seini Moimoi | Sep 8, 2022 | Portfolio News
Axonics® Announces First Patient Implants in Canada With New Recharge-Free Sacral Neuromodulation System by Seini Moimoi | Sep 8, 2022 | Portfolio News
CuraSen Therapeutics Announces First Patients Treated with Novel Combination Therapy (CST-2032/CST-107) in Phase 2a Study of Mild Cognitive Impairment (MCI) or Mild Dementia Due to Parkinson’s or Alzheimer’s Disease by Seini Moimoi | Sep 7, 2022 | Portfolio News
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in Adults 65 Years and Older by Seini Moimoi | Sep 6, 2022 | Portfolio News
Somatus Names New Medical Executive to Direct the Delivery of World-Class Kidney Care by Seini Moimoi | Aug 25, 2022 | Portfolio News
Aptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy Bodies by Seini Moimoi | Aug 25, 2022 | Portfolio News
89bio Announces Completion of Enrollment in ENLIVEN, the Phase 2b Trial of Pegozafermin for the Treatment of NASH by Seini Moimoi | Aug 18, 2022 | Portfolio News
